Search Results 2601-2610 of 17372 for Selective mutism

1. Magnetoencephalography (MEG) Recordings To Interrogate The Brain - Mayo Clinic

   MEG is a non-invasive neuroimaging technique that records the magnetic fields produced by neural activity. The MEG machine is completely passive, does not emit ...

2. A Study of AFP464 for Treating Patients with Solid Tumors that are Metastatic or Resistant to Treatment, and Cannot Be Removed By Surgery - Mayo Clinic

   Drugs used in chemotherapy, such as AFP464, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from ...

3. Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy - Mayo Clinic

   This is a dose escalation followed by dose expansion study of TL32711 in combination with 5-Azacitidine in subjects with Myelodysplastic syndrome who are naïve, ...

4. Trial of Anakinra (Plus Zinc), or Prednisone in Patients With Severe Alcoholic Hepatitis - Mayo Clinic

   Prednisone is the standard of care but is associated with a modest and transient survival benefit at best and increased risk of severe bacterial and fungal ...

5. A Study to Evaluate Single DNA Molecule Optical Imaging to Diagnose Facioscapulohumeral Muscular Dystrophy (FSHD) - Mayo Clinic

   The purpose of this study is to evaluate a novel direct single DNA molecule optical imaging system (Bionano) for the FSHD diagnosis. Participation eligibility.

6. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

   Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Bevacizumab blocks the ability of tumors to grow new blood vessels and ...

7. Study Evaluating The Efficacy And Safety Of Artesunate - Mayo Clinic

   About this study. This study is a randomized, open-label, active comparator-controlled, dose-ranging trial of the efficacy and safety of IV artesunate in ...

8. First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors - Mayo Clinic

   TP-0903 is a novel oral inhibitor that targets AXL kinase. Preclinical studies have shown promising antitumor activity of TP-0903 as a single agent against a ...

9. Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth - Mayo Clinic

   About this study. The potential role of Small bowel bacterial overgrowth (SBBO) in weight loss occurring in patients with PD has not previously been ...

10. Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-Hodgkin Lymphoma - Mayo Clinic

    About this study. RATIONALE: Collecting and storing samples of tissue from patients with cancer to test in the laboratory may help the study of cancer in ...